The incidence of pulmonary arterial hypertension (PAH) is rare in France, but it carries a high economic burden, a…
Articles by Alberto Molano, PhD
Adverse effects are associated with poor adherence to phosphodiesterase-5 inhibitors (PDE-5I) as treatment for patients with pulmonary arterial hypertension (PAH)…
New data support the safety and effectiveness of TIVUS (therapeutic intra-vascular ultrasound) for patients with pulmonary arterial hypertension (PAH)…
Dacomitinib, a medicine recently approved by the U.S. Food and Drug Administration for the treatment of certain forms of…
Teva Pharmaceutical Industries announced the launch of a generic version of Adcirca (tadalafil) under the brand name ALYQ…
Plans to create and license diagnostic tools to help transplant surgeons rapidly and accurately assess the health of a lung…